○Shunta Okabe1, Keishun Iwao1, Tesshu Hori2, Shouhei Ikuta3, Satoko Hattori4, Keizou Takao5,6,7, Tuyoshi Miyakawa4, Chieko Koike1,2,3,8 (1. College of Pharmaceutical Science, Ritsumeikan Univ., 2. Graduate school of Pharmaceutical Science, Ritsumeikan Univ., 3. Graduate school of life Sciences, Ritsumeikan Univ., 4. Center for Medical Science, Fujita Health Univ., 5. Graduate school of Medicine and Pharmaceutical Science, Toyama Univ., 6. Administration Center for Promotion of Research, Organization for Promotion of Research, Toyama Univ., 7. Research Center for Idling Brain Science, Toyama Univ., 8. Center for Systems Vision Science, Research Organization for Science and Technology, Ritsumeikan Univ.)
Session information
Poster Presentation
(C) Pharmaceutical Biology
[27P1-am1] Brain and nervous system
Mon. Mar 27, 2023 10:00 AM - 11:40 AM [Room P1] Gymnasium (1F)
○keishun iwao1, Shunta Okabe1, Tesshu Hori2, Shoheiei Ikuta3, Satoko Hattori4, Keizo Takao5,6,7, Tsuyoshi Miyakawa4, Chieko Koike1,2,3,8 (1. College of Pharmaceutical Science, Ritsumeikan Univ., 2. Graduate school of Pharmaceutical Science, Ritsumeikan Univ., 3. Graduate school of life Sciences, Ritsumeikan Univ., 4. Center for Medical Science, Fujita Health Univ., 5. Graduate school of Medicine and Pharmaceutical Science, Toyama Univ., 6. Administration Center for Promotion of Research, Organization for Promotion of Research, Toyama Univ., 7. Research Center for Idling Brain Science, Toyama Univ., 8. Center for Systems Vision Science, Research Organization for Science and Technology, Ritsumeikan Univ.)
○Rin Sawada1, Akiko Ueno2, Yusuke Inoue1, Chiseto Maejima3, Yoshimi Takai4, Jun Miyoshi5, Chieko Koike1,2,3,6 (1. Grad. Sch. Pharm., Ritsumeikan Univ., 2. R-GIRO., Ritsumeikan Univ., 3. Col. Pharm. Sci., Ritsumeikan Univ. , 4. Grad. Sch. Med., Kobe Univ., 5. Osaka Medical Center for Cancer and Cardiovascular Diseases, 6. Center for Systems Vision Science, Research Organization of Science and Technology, Ritsumeikan Univ.)
○Naho Baba1, Rin Sawada2, Peiyu Zhang2, Akiko Ueno3, Fumio Nakamura4, Masayoshi Mishina5, Chieko Koike1,2,3,6 (1. Col. Pharm. Sci., Ritsumeikan Univ., 2. Grad. Sch. Pharm. Sci., Ritsumeikan Univ., 3. R-GIRO, Ritsumeikan Univ. , 4. Sch. Med., Tokyo Women’s Medical Univ. , 5. Res. Org. Sci. Tech., Ritsumeikan Univ., 6. CSVS., Ritsumeikan Univ.)
○Toshiki Maeda1, Hironobu Shuto2,3, Takesi Matsuyama3, Chieko Koike1,2,4,5 (1. College of Pharmaceutical Science, Ritsumeikan Univ., 2. Graduate school of Pharmaceutical Science, Ritsumeikan Univ., 3. Vision Care Inc, 4. Graduate school of life Sciences, Ritsumeikan Univ., 5. Center for Systems Vision Science, Research Organization for Science and Technology, Ritsumeikan Univ.)
[27P1-am1-070S] Regulation of CD33 alternative splicing by HNRNPA1 and its evolutionary conservation
○Riho Komuro1, Yuka Honda1, Motoaki Yanaizu1, Masami Nagahama1, Yoshihiro Kino1 (1. Meiji Pharmaceutical Univ.)
○Nami Tsuchiya1, Motoaki Yanaizu1, Makoto Araki1, Kenji Kontani1, Yoshihiro Kino1 (1. Meiji Pharmaceutical Univ.)
○Ruri Kojima1, Masaki Ishii1, Shinya Ohata1 (1. Faculty. Sch. Pharm. Sci., Musashino Univ.)
○Toshiyuki Yamada1, Aemi Taguchi1, Haruka Fushimi1, Taiga Kurihara1, Hiroyuki Yamamoto1 (1. Nihon Pharm. Univ. , Dept. of Microbiol. and Mol. Cell Biol.)
○Shotaro Kawano1, Tomohiro Takada1, Yukiko Ayusawa1, Hotaka Fukushima1, Daiki Miura1, Ryota Hashimoto2, Hitoshi Hashimoto2,3,4,5,6,7, Takanobu Nakazawa1,2 (1. Grad. Sch. of Life Sci., Tokyo Univ. Agr., 2. Dept. Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, 3. Grad. Sch. Pharmaceut. Sci., Osaka Univ. , 4. United Grad. Sch. Child Dev., Osaka Univ. , 5. Div. Biosci., Inst. Datability Sci., Osaka Univ., 6. Transdimensional Life Imaging Div., Inst. Open Transdiscip. Res. Initiatives, Osaka Univ., 7. Grad. Sch. Med., Osaka Univ.)
○Hiroyuki Mizuno1, Yuji Ikegaya1,2 (1. Grad Sch Pharmaceut Sci, Univ Tokyo, 2. Inst AI Beyond, Univ Tokyo)
○Tomohiro Takada1, Shotaro Kawano1, Yukiko Ayusawa1, Hotaka Fukushima1, Daiki Miura1, Ryota Hashimoto2, Hitoshi Hashimoto2,3,4,5,6,7, Takanobu Nakazawa1,2 (1. Grad. Sch. of Life Sci., Tokyo Univ. Agr., 2. Dept. Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, 3. Grad. Sch. Pharmaceut. Sci., Osaka Univ., 4. United Grad. Sch. Child Dev., Osaka Univ., 5. Div. Biosci., Inst. Datability Sci., Osaka Univ., 6. Transdimensional Life Imaging Div., Inst. Open Transdiscip. Res. Initiatives, Osaka Univ., 7. Grad. Sch. Med., Osaka Univ.)
○Kohei Arimura1, Hironori Izumi2, Hisashi Mori2, Shin'ya Ohmori3, Satoru Mitazaki1, Mamoru Fukuchi1 (1. Mol. Neurosci., Fac. Pharm., Takasaki Univ. of Hlth & Welfare, 2. Fac. Med., Univ. of Toyama, 3. Fac. Pharm., Takasaki Univ. of Hlth & Welfare)
○Hibiki Nakasone1, Yuka Matsuoka1, Rento Kasahara1, Mamoru Fukuchi1 (1. Fac. Pharm., Takasaki Univ. of Hlth & Welfare)
○Torashige Sono1, Kaneyasu Nishimura1,3, Takashi Ohgita2, Haruka Ito1, Hiroyuki Saito2, Kazuyuki Takata1 (1. Div. Integ. Pharm. Sci., Kyoto Pharm. Univ., 2. Dept. Biophys. Chem., Kyoto Pharm. Univ., 3. Grad. Sch. Brain Sci., Doshisha Univ.)
○Akari Okuyama1, Yuya Akimoto1, Hotaka Fukusima1, Daiki Miura1, Takanobu Nakazawa1 (1. Grad. Sch. of Life Sci., Tokyo Univ. Agr.)
○Yuya Akimoto1, Masayuki Baba2, Hotaka Fukushima1, Daiki Miura1, Hitoshi Hashimoto2,3,4,5,6,7, Ryota Hashimoto3, Takanobu Nakazawa1,3 (1. Grad. Sch. of Life Sci., Tokyo Univ. Agr., 2. Grad. Sch. Pharmaceut. Sci., Osaka Univ., 3. Dept. Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4. United Grad. Sch. Child Dev., Osaka Univ., 5. Div. Biosci., Inst. Datability Sci., Osaka Univ., 6. Transdimensional Life Imaging Div., Inst. Open Transdiscip. Res. Initiatives, Osaka Univ., 7. Grad. Sch. Med., Osaka Univ.)
○Yoshikazu Morishita1, Ayame Kubo2, Kyoka Nishimura2, Rintaro Shimizume1,2, Yuki Takamura1,2, Yuto Yokoi1, Natsuko Hitora-Imamura2, Masabumi Minami2, Hiroshi Nomura1,2 (1. Graduate School of Medical sciences, Nagoya City University, 2. Graduate School of Pharmaceutical Sciences, Hokkaido University)
○Mika Matsumura1,2, Narumi Taketomi1, Shingo Saio1,2, Kanna Konishi1,2, Tadashi Okamoto2, Masamitsu Ichihashi2, Ken-ichi Mizutani1 (1. Grad. Sch. Pharm. Sci. Kobe Gakuin Univ., 2. Sch. Pharm. Sci. Kobe Gakuin Univ.)
○Tohru Yamamoto1, Daiki Ojima1, Atsushi Tada1, Naohiro Kurokawa2, Hiroo Takahashi1, Takashi Tominaga2, Kishimoto Yasushi2,3 (1. Fac. Med., Kagawa Univ., 2. Fac. Kagawa Pharm. Tokushima Bunri Univ., 3. Fac. Pharm. Teikyo Univ.)
○Kazuya Yoshioka1, Taiki Okada1, Miku Tanabe1, Daiki Miura1, Hotaka Fukushima1, Rie Ishikawa2, Satoshi Kida2, Takanobu Nakazawa1 (1. Graduate School of Life Sciences, Tokyo University of Agriculture, 2. Graduate School of Agriculture and Life Sciences, The University of Tokyo)
○Kao Hashimoto1,2, Yasuyuki Nagumo2, Keita Iio2,3, Yuki Saito1,2, Yukiko Ishikawa2, Noriki Kutsumura1,2,3, Takeshi Sakurai1,2, Masashi Yanagisawa1,2, Tsuyoshi Saitoh1,2, Hiroshi Nagase2,3 (1. Grad. Sch. Comp Hum. Sci., Univ. Tsukuba, 2. IIIS, Univ. Tsukuba, 3. Grad. Sch. Pure Appl. Sci., Univ. Tsukuba)
○Kanna Konishi1,2, Yoshimi Abe1, Sakiho Koyama1, Shingo Saio1, Teruaki Masutani3, Iddamalgoda Arunasiri3, Tadashi Okamoto2, Masamitsu Ichihashi2, Ken-ichi Mizutani1 (1. Grad. Sch. Pharm. Sci., Kobe Gakuin Univ., 2. Sch. Pharm. Sci., Kobe Gakuin Univ., 3. Research&Development,Ichimaru Pharcos Co,Ltd,)
○Momoko Miyazawa1, Ayumi Nakashima1, Toshiharu suzuki2, Hidenori Taru2 (1. Fac. Pharm. Sci., Univ. Hokkaido, 2. Grad. Sch. Pharm. Sci., Univ. Hokkaido)
○Mami Hino1, Kanako Ichihara1, Kouki Fujinaga1, Syou Kataoka1, Masayuki Nakanishi1, Hiroshi Nomoto1 (1. Coll. Pharm. Sci., Matsuyama Univ.)
○Hiroo Takahashi1, Daiki Ojima1, Atsushi Tada1, Akio Tsuboi2, Tohru Yamamoto1 (1. Faculty of Med., Kagawa Univ., 2. Grad. Sch. Front. Biosci., Osaka Univ.)
○Ayuko Masaki1, Saki Egashira1, Rie Mukai1, Kana Kumagai1, Takafumi Nakano2, Keiichi Irie1, Yuta Yamashita1, Kazunori Sano1, Tomomitsu Satho1, Kenichi Mishima1 (1. Dept.pharmacol.Fukuoka Univ, 2. Dept.pharm.Fukuoka Univ.Hosp.)
○Saki Egashira1, Ayuko Masaki1, Rie Mukai1, Takafumi Nakano1,2, Masato Hosokawa1, Fuyuki Kametani3, Keiichi Irie1, Tomomitsu Satho1, Yuta Yamashita1, Kazunori Sano1, Kenichi Mishima1 (1. Dept.pharmacol.Fukuoka Univ., 2. Dept.pharm.Fukuoka Univ.Hosp., 3. Tokyo metroplitan institute of Medical Sci.)
○Kazuna Kikkawa1, Masahiro Fujimuro1, Yuichi Sekine1 (1. Kyoto Pharm. Univ.)
[27P1-am1-094S] Effects of stress hormone-induced depression on the heterochromatin state of neurons
○Yuka Nakamura1, Yuki Kitanishi2, Daichi Kawaguchi2, Yukiko Gotoh2 (1. Fac. of Pharm. Sci., Univ. of Tokyo, 2. Grad. Sch. Pharm. Sci., Univ. of Tokyo)
○Mamoru Matsubara1, Harukazu Fukami2 (1. Pharm. Sci., Gifu Univ. Med. Sci., 2. Bioenv. Sci. Kyoto Univ. Adv. Sci.)
○ikumi mizuno1, shingo matsuda1,2, yoshimi ogawa1, akihiro mizutani1 (1. Grad. Sch. Pharmaceutical., Shouwa Pharmaceutical Univ., 2. Grad. Sch. Medicine., Chiba Univ.)
○Yasuaki Takahara1, Naomi Hasegawa3, Koichi Hamada2, Akihiro Mizutani2 (1. Grad. Sch. Pharm Sci., Showa Pharm. Univ., 2. Showa Pharm. Univ., 3. Natl. Inst. of Ment. Health., Natl. Ctr. of Neurol. & Psychiat.)
○Kenji Senoo1, Junya Onodera1, Akira Murakami1, Koki Okabe1, Shibasaki Koji2, Yuji Ikegaya1,3, Ryuta Koyama1,3 (1. Grad. Sch. Pharm. Sci., Univ Tokyo, 2. Grad. Sch. of Human Health Sci., Univ Nagasaki, 3. Inst AI Beyond, Univ Tokyo)